|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-6-1
|
|
pubmed:abstractText |
To determine whether time to treatment (TTT) has an effect on overall survival (OS) in patients with unresectable or medically inoperable Stage III non-small cell lung cancer (NSCLC) and whether patient or treatment factors are associated with TTT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
790-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19231108-Adenocarcinoma,
pubmed-meshheading:19231108-Adult,
pubmed-meshheading:19231108-Age Factors,
pubmed-meshheading:19231108-Aged,
pubmed-meshheading:19231108-Aged, 80 and over,
pubmed-meshheading:19231108-Analysis of Variance,
pubmed-meshheading:19231108-Carcinoma, Large Cell,
pubmed-meshheading:19231108-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19231108-Carcinoma, Squamous Cell,
pubmed-meshheading:19231108-Combined Modality Therapy,
pubmed-meshheading:19231108-Female,
pubmed-meshheading:19231108-Follow-Up Studies,
pubmed-meshheading:19231108-Hospitals, Federal,
pubmed-meshheading:19231108-Humans,
pubmed-meshheading:19231108-Karnofsky Performance Status,
pubmed-meshheading:19231108-Lung Neoplasms,
pubmed-meshheading:19231108-Male,
pubmed-meshheading:19231108-Middle Aged,
pubmed-meshheading:19231108-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:19231108-Retrospective Studies,
pubmed-meshheading:19231108-Risk Assessment,
pubmed-meshheading:19231108-Sex Factors,
pubmed-meshheading:19231108-Survival Analysis,
pubmed-meshheading:19231108-Time Factors,
pubmed-meshheading:19231108-United States
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Time to treatment in patients with stage III non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
